Tim Wiltshire
University of North Carolina at Chapel Hill
H-index: 44
North America-United States
Top articles of Tim Wiltshire
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Model‐Based Prediction of Irinotecan‐Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model | Clinical Pharmacology & Therapeutics | Spinel Karas Ron HJ Mathijssen Ron HN van Schaik Alan Forrest Tim Wiltshire | 2024/2/12 |
MKX-AS1 Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients | Pharmaceuticals | Ricardo D Gonzalez George W Small Adrian J Green Farida S Akhtari Alison A Motsinger-Reif | 2023/5/17 |
RYK Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients | Pharmaceuticals | Ricardo D Gonzalez George W Small Adrian J Green Farida S Akhtari Tammy M Havener | 2023/5/10 |
Pharmacogenomic Analyses Implicate B Cell Developmental Status and MKL1 as Determinants of Sensitivity toward Anti-CD20 Monoclonal Antibody Therapy | Cells | George W Small Farida S Akhtari Adrian J Green Tammy M Havener Michael Sikes | 2023/6/7 |
The feasibility and potential of pharmacogenetics to reduce adverse drug events in nursing home residents | Journal of the American Geriatrics Society | Christine E Kistler C Adrian Austin Junjian J Liu Madison Cauble Andrew Wise | 2022/5 |
Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic | Clinical and Translational Science | Jing Zhu Gauri Rao Paul M Armistead Jonathan Ptachcinski Daniel L Weiner | 2022/3 |
North Carolina’s multi-institutional pharmacogenomics efforts with the North Carolina Precision Health Collaborative | Jai N Patel Deepak Voora Gillian Bell Jill Bates Amber Cipriani | 2021/1 | |
Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients | Clinical and Translational Science | Jing Zhu Olivia Campagne Chad D Torrice Gabrielle Flynn Jordan A Miller | 2021/5 |
Cost-effectiveness of multigene pharmacogenetic testing in patients with acute coronary syndrome after percutaneous coronary intervention | Value in Health | Olivia M Dong Stephanie B Wheeler Gracelyn Cruden Craig R Lee Deepak Voora | 2020/1/1 |
Projected impact of pharmacogenomic testing on medications beyond antiplatelet therapy in percutaneous coronary intervention patients | Pharmacogenomics | Rachel M Black Alexis K Williams Lindsay Ratner Daniel J Crona Tim Wiltshire | 2020/3 |
Importance of Testing Rarer Alleles (CYP3A5* 6 and CYP3A5* 7) for Genotype-Guided Tacrolimus Dosing | Ivy Xue | 2020/2/10 | |
Influence of germline genetics on tacrolimus pharmacokinetics and pharmacodynamics in allogeneic hematopoietic stem cell transplant patients | THE ONGOING QUEST FOR PRECISION: TACROLIMUS DOSING IN ADULT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS | J Zhu A Deal T Patel J Miller C Torrice | 2021 |
Pharmaconutrigenetics: The Impact of Genetics on Nutrient–Drug Interactions | Olivia Dong Tim Wiltshire | 2020/1/1 |
